EAM Investors, LLC - AVALANCHE BIOTECHNOLOGIES IN ownership

Back to all holdings Add to watchlist

AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 100 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
EAM Investors, LLC ownership history of AVALANCHE BIOTECHNOLOGIES IN
ValueSharesWeighting
Q1 2015$800,000
-38.1%
19,732
-17.6%
0.09%
-48.9%
Q4 2014$1,293,000–23,940–0.18%–
 Download
Other shareholders

There were no reported owners of AVALANCHE BIOTECHNOLOGIES IN in Q2 2015.

NameSharesValueWeighting ↓
View complete list of AVALANCHE BIOTECHNOLOGIES IN shareholders